Period
2001 - 2003
Number
5
Co-Authors
Pharmacokinetic pharmacodynamic modeling and an example of its application to drug delivery (2003)
Triggs, T.E.J.
Benefits and limitations in using distortion product otoacoustic emissions to monitor for ototoxic hearing loss in paediatric oncology patients (2002)
Beahan, N. M., Kei, K.K.J., Suppiah, R., Young, J., Triggs, T.E.J., Charles, B. G.
Feasibility of establishing an early indicator for ototoxicity in children using otoacoustic emissions (2001)
Beahan, N., Kei, K.K.J., O'Rourke, C., Sockalingam, R., Smyth, V., Young, J., ...
Parkinson's Disease: Aiding quality of life. (2001)
Therapeutic drug monitoring advisory service taking kinetics to the clinician and patient: A new model of pharmaceutical care. (2001)
Cowley, D., Haggitt, C., Hung, R., McGuire, T., Lockhart, S., Rasiah, R. L., ...